1.     Fang Huang, Xiangyu Lu, Le Kuai, Yi Ru, Jing-Si Jiang, Jiankun Song, Si Chen, Lijie Mao, Yongyong Li, Bin Li*, Haiqing Dong¹*, Jianlin Shi^2,3*Dual-site biomimetic Cu/Zn-MOF for atopic dermatitis catalytic therapy via suppressing FcγR-mediated phagocytosis,J. Am. Chem. Soc.,2024,146, 5, 3186-3199.

2.  Weimin Yin^1,#, Jiao Chang^2,#, Jiuyuan Sun², Yuge Zhao², Shiyu Chen¹, Hui Zhi¹, Jie Zang², Tingting Zhang², Yongyong Li^2*, Haiqing Dong^1*, Arginine Nanoparticles Mediated Closed-Loop Ferroptosis Enhancement for T Cell Activity Boosting in Cancer Immunotherapy, Applied Materials Today, 2024, 36, 102047. (IF=8.3)

3. Jiao Chang, Weimin Yin, Hui Zhi, Shiyu Chen, Jiuyuan Sun, Yuge Zhao, Li Huang,Liangyi Xue, Xiaoyou Zhang, Tingting Zhang, Haiqing Dong,* and Yongyong Li*, Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy. Small 2024, 2308565.

4. Yan Yang, Yushan Yang, Jingsi Jiang, Zongzhou Wu, Juyuan Sun, Hui Zhi, ShiYu Chen, Le Kuai, Bin Li*, Haiqing Dong*Arginine-Nanoenzyme with Timely Angiogenesis for Promoting Diabetic Wound Healing, ACS Applied Materials & interfaces, 2024, 16, 8, 9640–9655 

5.  Jingjing Gu, Jiao Chang, Jiuyuan Sun, Weimin Yin, Tingting Zhang, Jie Zang, Yuge Zhao, Yiqiong Liu , Xiao Zheng, Shiyu Chen, Hui Zhi, Leiyu Feng, Yongyong Li,* Haiqing Dong,*Suppressing the Hypoxia-Adenosinergic Axis by a Tailored Nanoreactor for Enhanced Photothermal Immunotherapy, Small Science, 2024, 2300242.

6. Jiuyuan Sun, Yiqiong Liu, Yuge Zhao, Weimin Yin, Zichen Yang, Jiao Chang, Li Huang, Shiyu Chen, Hui Zhi, Liangyi Xue, Xiaoyou Zhang, Haiqing Dong, Yongyong Li*.Erythrocyte-Derived Bioactive Nanovesicles Reverse the Immunosuppressive Function of Adenosine for Tumor Photoimmunotherapy.Adv. Funct. Mater. 2024, 2400114.

7. Yuge Zhao, Weimin Yin, Zichen Yang, Jiuyuan Sun, Jiao Chang, Li Huang, Liangyi Xue, Xiaoyou Zhang, Hui Zhi, Shiyu Chen, Nana Chen, 

 Yongyong Li*,Nanotechnology-enabled M2 macrophage polarization and ferroptosis inhibition for targeted inflammatory bowel disease treatment. J Control Release. 2024, 367:339-353.